You just read:

New England Journal Of Medicine Publishes Data From Phase 3 inTandem3 Study Of Sotagliflozin In Patients With Type 1 Diabetes

News provided by

Lexicon Pharmaceuticals, Inc.

Sep 13, 2017, 04:31 ET